Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Metagenomi Inc. Common St...

    NASDAQ: MGX · Real-Time Price · USD
    1.43
    -0.02 (-1.38%)
    At close: Jun 13, 2025, 3:59 PM
    1.40
    -2.10%
    After-hours: Jun 13, 2025, 06:56 PM EDT

    Metagenomi Common Stock Statistics

    Share Statistics

    Metagenomi Common Stock has 37.38M shares outstanding. The number of shares has increased by -0.22% in one year.

    Shares Outstanding

    n/a
    		 37.38M

    Shares Change (YoY)

    n/a
    		 -0.22%

    Shares Change (QoQ)

    n/a
    		 -0.11%

    Owned by Institutions (%)

    n/a
    		 27.98%

    Shares Floating

    n/a
    		 21.78M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,046

    FTD / Avg. Volume

    n/a
    		 0.27%

    Short Selling Information

    The latest short interest is 2.13M, so 5.7% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.13M

    Short % of Shares Out

    n/a
    		 5.7%

    Short % of Float

    n/a
    		 7.84%

    Short Ratio (days to cover)

    n/a
    		 8.41

    Valuation Ratios

    The PE ratio is -1.73 and the forward PE ratio is -0.69. Metagenomi Common Stock's PEG ratio is -0.06.

    PE Ratio

    n/a
    		 -1.73

    Forward PE

    n/a
    		 -0.69

    PS Ratio

    n/a
    		 2.58

    Forward PS

    n/a
    		 5.3

    PB Ratio

    n/a
    		 0.58

    P/FCF Ratio

    n/a
    		 -1.2

    PEG Ratio

    n/a
    		 -0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Metagenomi Common Stock.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.91, with a Debt / Equity ratio of 0.19.

    Current Ratio

    n/a
    		 6.91

    Quick Ratio

    n/a
    		 6.91

    Debt / Equity

    n/a
    		 0.19

    Debt / EBITDA

    n/a
    		 -0.55

    Debt / FCF

    n/a
    		 -0.41

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $258,886.14

    Profits Per Employee

    n/a
    		 $-386,425.74

    Employee Count

    n/a
    		 202

    Asset Turnover

    n/a
    		 0.16

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -5.51M

    Effective Tax Rate

    n/a
    		 6.6%

    Stock Price Statistics

    The stock price has increased by -74.23% in the last 52 weeks. The beta is -0.33, so Metagenomi Common Stock's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.33

    52-Week Price Change

    n/a
    		 -74.23%

    50-Day Moving Average

    n/a
    		 1.59

    200-Day Moving Average

    n/a
    		 2.21

    Relative Strength Index (RSI)

    n/a
    		 37.9

    Average Volume (20 Days)

    n/a
    		 388,403

    Income Statement

    In the last 12 months, Metagenomi Common Stock had revenue of 52.3M and earned -78.06M in profits. Earnings per share was -2.36.

    Revenue

    n/a
    		 52.3M

    Gross Profit

    n/a
    		 52.3M

    Operating Income

    n/a
    		 -88.9M

    Net Income

    n/a
    		 -78.06M

    EBITDA

    n/a
    		 -83.49M

    EBIT

    n/a
    		 -88.9M

    Earnings Per Share (EPS)

    n/a
    		 -2.36
    Full Income Statement

    Balance Sheet

    The company has 27.39M in cash and 45.78M in debt, giving a net cash position of -18.39M.

    Cash & Cash Equivalents

    n/a
    		 27.39M

    Total Debt

    n/a
    		 45.78M

    Net Cash

    n/a
    		 -18.39M

    Retained Earnings

    n/a
    		 -223M

    Total Assets

    n/a
    		 297.87M

    Working Capital

    n/a
    		 193.3M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -109.07M and capital expenditures -3.11M, giving a free cash flow of -112.19M.

    Operating Cash Flow

    n/a
    		 -109.07M

    Capital Expenditures

    n/a
    		 -3.11M

    Free Cash Flow

    n/a
    		 -112.19M

    FCF Per Share

    n/a
    		 -3
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -170% and -149.26%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -170%

    Pretax Margin

    n/a
    		 -159.81%

    Profit Margin

    n/a
    		 -149.26%

    EBITDA Margin

    n/a
    		 -159.66%

    EBIT Margin

    n/a
    		 -170%

    FCF Margin

    n/a
    		 -214.53%

    Dividends & Yields

    MGX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MGX is $14, which is 879% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $14

    Price Target Difference

    n/a
    		 879%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.75

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist